Assembly Biosciences, Inc. · NASDAQ:ASMB
Paradigm Biocapital Advisors LP reported a 5.40% stake in Assembly Biosciences, Inc. (Schedule 13G)
Event May 4, 2026 · Filed May 11, 2026
Paradigm Biocapital Advisors LP reported a 5.40% stake in Assembly Biosciences, Inc., 865,251 shares, as a passive investor on May 4, 2026. Filed May 11, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 865,251
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Paradigm BioCapital Advisors LP | 5.40% | 865,251 |
| Paradigm BioCapital Advisors GP LLC | 5.40% | 865,251 |
| Senai Asefaw, M.D. | 5.40% | 865,251 |
| Paradigm BioCapital International Fund Ltd. | 4.80% | 758,963 |
Source
Related
- Assembly Biosciences, Inc.
- Paradigm Biocapital Advisors LP
- Assembly Biosciences, Inc. shareholders
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 4, 2026
- Form 4 · Bjorkquist Jeanette M · Jun 18, 2026
- Form 4 · Gaggar Anuj · Jun 5, 2026
- Form 4 · White Nicole S · Jun 5, 2026